Morihito Okada
Morihito Okada publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Lung Cancer Diagnosis and Treatment, Lung Cancer Treatments and Mutations and Lung Cancer Research Studies.
- World rank
- #656,735 of 7,710,434 ranked researchers
- Rank in Japan
- #7,436 of 383,136
- Works
- 428
- Citations
- 13k
- Citations per work
- 29.9
What does Morihito Okada research?
Morihito Okada's work is mostly in Medicine (82%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences35282.3%
- Medicine35282.3%
- Everything else6014.0%
- Life Sciences163.7%
- 1Pulmonary and Respiratory Medicine50% of their works
- 2Oncology12% of their works
- 3Surgery8% of their works
- 4Radiology, Nuclear Medicine and Imaging8% of their works
- 5Hepatology4% of their works
- 6Cancer Research4% of their works
Research topics
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Radiomics and Machine Learning in Medical Imaging
- Pleural and Pulmonary Diseases
- Hepatocellular Carcinoma Treatment and Prognosis
- Esophageal Cancer Research and Treatment
- Occupational and environmental lung diseases
Which keywords describe Morihito Okada's research?
The keywords of their largest research topics: Chemotherapy, CT Screening, Lung Cancer, Clinical Trials, Targeted Therapy, ALK Inhibitors, EGFR Mutations and Immunotherapy.
- Malignant Pleural Mesothelioma
- Preoperative Chemoradiotherapy
- Liver Cancer
- Pleural Effusion
- Radiomics
- Small-Cell Lung Cancer
- Immunotherapy
- ALK Inhibitors
- Clinical Trials
- CT Screening
- Chemotherapy
- Lung Cancer
- Targeted Therapy
- EGFR Mutations
- Genomic Profiles
- Medical Imaging
- Empyema
- Hepatocellular Carcinoma
- Esophageal Carcinoma
- BAP1 mutations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Chemotherapy3162 topics
- CT Screening2421 topic
- Lung Cancer2421 topic
- Clinical Trials2332 topics
- Targeted Therapy2332 topics
- ALK Inhibitors1591 topic
- EGFR Mutations1591 topic
- Immunotherapy1052 topics
- Genomic Profiles741 topic
- Small-Cell Lung Cancer741 topic
- Medical Imaging631 topic
- Radiomics631 topic
- Empyema451 topic
- Pleural Effusion451 topic
- Hepatocellular Carcinoma431 topic
- Liver Cancer431 topic
- Esophageal Carcinoma361 topic
- Preoperative Chemoradiotherapy361 topic
- BAP1 mutations311 topic
- Malignant Pleural Mesothelioma311 topic
Where does Morihito Okada work?
Morihito Okada's main affiliation in the publication record is Hiroshima University, Japan.
How many publications and citations does Morihito Okada have?
OpenAlex counts 428 works and 12,786 citations for Morihito Okada, an h-index of 53, ranking #656,735 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Morihito Okada
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Morihito Okada. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.